Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
29
30
Next >
What 8 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
January 30, 2023
Tickers
REGN
Tags
REGN
BZI/AAR
Benzinga
From
Benzinga
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
Tickers
AAPL
AMD
AMGN
AMZN
Tags
SNAP
AAPL
LCRX
From
Benzinga
Wall Street Thinks These 2 Blazing Healthcare Stocks Could Have 21% to 30% Upside in 2023
January 23, 2023
Tickers
ELV
REGN
SNY
Tags
ELV
Market News
SNY
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2023
January 20, 2023
Tickers
ACGL
AFG
AIG
AJG
Tags
RNR
LCII
AWH
From
Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
January 19, 2023
Tickers
REGN
Tags
Benzinga
BZI/POD
Market News
From
Benzinga
Analyst Ratings for Regeneron Pharmaceuticals
January 11, 2023
Tickers
REGN
Tags
REGN
Analyst Ratings
Market News
From
Benzinga
Check Out What Whales Are Doing With REGN
January 10, 2023
Tickers
REGN
Tags
Markets
Options
REGN
From
Benzinga
Check Out What Whales Are Doing With REGN
January 09, 2023
Tickers
REGN
Tags
Benzinga
Market News
BZI/UOA
From
Benzinga
What This Drug News Could Mean for Sanofi Shareholders
January 08, 2023
Tickers
REGN
SNY
Tags
REGN
Recent Press Releases
SNY
From
Motley Fool
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
January 06, 2023
Tickers
ABT
AMGN
BAC
BMY
Tags
REGN
AMGN
BAC
From
InvestorPlace
CytomX Shares Move Higher On Collaborating Pact With This Famed COVID-19 Vaccine Maker
January 06, 2023
Tickers
CTMX
MRNA
REGN
Tags
Briefs
Penny Stocks
Movers
From
Benzinga
3 Growth Stocks That Could Rocket Higher in 2023
January 06, 2023
Tickers
ALNY
QURE
REGN
Tags
Market News
REGN
ALNY
From
Motley Fool
Jim Cramer Says He's 'Still Feeling Good' About These 5 Stocks From 'Mutilated' Nasdaq
January 05, 2023
Tickers
AEP
DLTR
PEP
PG
Tags
Analyst Color
Jim Cramer
REGN
From
Benzinga
2 Unstoppable Dividend Growth Stocks to Buy in 2023 and Beyond
December 29, 2022
Tickers
AMGN
CVS
REGN
Tags
Market News
REGN
CVS
From
Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
Tickers
BGNE
BIIB
CDTX
CHRS
Tags
MRK
Covid/19
ESALY
From
Benzinga
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
December 24, 2022
Tickers
AMGN
AZN
HZNP
JNJ
Tags
NVO
Recent Press Releases
AMGN
From
Motley Fool
Ahead of a year of big unknowns, here are two sectors investors should consider, says this money manager
December 22, 2022
Tickers
AAL
AAPL
AMC
AMZN
Tags
CL/1
ENPH
DAL
From
MarketWatch
2 Best Biotech Stocks to Buy Right Now
December 16, 2022
Tickers
AMGN
AZN
REGN
SNY
Tags
AZN
Market News
AMGN
From
Motley Fool
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis
December 15, 2022
Tickers
REGN
SNY
Tags
Briefs
REGN
SNY
From
Benzinga
Regeneron Reveals An Early Cut Data From Follicular Lymphoma Study At ASH Meeting
December 13, 2022
Tickers
REGN
Tags
Benzinga
Health Care
Market News
From
Benzinga
Regeneron Highlights Its First Phase 2 Data To Build Case In CD20xC3 Bispecific Space
December 12, 2022
Tickers
REGN
Tags
REGN
Briefs
News
From
Benzinga
Our 7 Top Biotech Stock Picks for 2023
December 09, 2022
Tickers
CORT
GMAB
NVO
REGN
Tags
UTHR
NVO
TECH
From
InvestorPlace
Will This Potential Approval Be a Winner for Sanofi's Shareholders?
December 09, 2022
Tickers
REGN
SNY
Tags
REGN
Recent Press Releases
SNY
From
Motley Fool
This fund beats the S&P 500 by using just 75 of its components. Here’s how it works.
December 08, 2022
Tickers
AAPL
AMZN
BRK-B
CI
Tags
GOOG
SPGP
TSLA
From
MarketWatch
Chinese Lockdown Effects Ripple Marketwide; A Solution Urgently Needed
December 08, 2022
Tickers
AAPL
LLY
PFE
REGN
Tags
Biotech
Benzinga
TSLA
From
Benzinga
Can These 2 Stocks Crush the Market Again in 2023?
December 04, 2022
Tickers
BIIB
ESALY
REGN
Tags
Market News
BIIB
ESALY
From
Motley Fool
Regeneron's Evkeeza Under FDA Priority Review For Younger Kids With Inherited Form Of High Cholesterol
November 30, 2022
Tickers
REGN
Tags
General
Large Cap
News
From
Benzinga
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent
November 30, 2022
Tickers
REGN
SNY
Tags
Health Care
Movers
News
From
Benzinga
2 Market-Beating Stocks That Can Continue Rising in 2023
November 30, 2022
Tickers
REGN
TMUS
Tags
Market News
TMUS
REGN
From
Motley Fool
Cramer On This Stock Down 65% Year-To-Date: 'I Do Believe It's Bottoming, But I Don't Know What Gets It Higher'
November 18, 2022
Tickers
BTAI
FDMT
REGN
SOFI
Tags
Market News
Top Stories
Benzinga
From
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.